Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aristolochic Acids Kidney AEs Subject Of Pending FDA Import Alert

This article was originally published in The Tan Sheet

Executive Summary

Herbal products containing aristolochic acids have been linked to reports of kidney failure and will be the subject of an import alert in the near future, FDA says in a May 16 letter to industry.

You may also be interested in...



Aristolochic Presence Shows Herbals Web Sales Policy Needed – NEJM Letter

The continued availability of herbal products containing aristolochic acid via the Internet shows the need for a policy on web sales of dangerous botanical products, according to two members of the Carcinogenic Potency Project, University of California - Berkeley

Aristolochic Presence Shows Herbals Web Sales Policy Needed – NEJM Letter

The continued availability of herbal products containing aristolochic acid via the Internet shows the need for a policy on web sales of dangerous botanical products, according to two members of the Carcinogenic Potency Project, University of California - Berkeley

Aristolochic Presence Shows Herbals Web Sales Policy Needed – NEJM Letter

The continued availability of herbal products containing aristolochic acid via the Internet shows the need for a policy on web sales of dangerous botanical products, according to two members of the Carcinogenic Potency Project, University of California - Berkeley

Related Content

Topics

UsernamePublicRestriction

Register

PS091246

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel